however, the safety and efficacy of such therapy have not been systematically evaluated Risk factors of statinfibrate-related myopathy include advanced age, female gender, low BMI, renal disease, diabetes mellitus, hypothyroidism, multisystem disease, fever, surgery, trauma, and strenuous physical exercise The likelihood and/or severity of myopathy also depend on pharmacologic properties of the statin and the fibrate, such as their enzymatic metabolism or excretion and/or their protein-regulated intercellular transport Fenofibrate or fenofibric acid may be fibrates of choice for statinfibrate therapy because, according to pharmacokinetic and postmarketing data, they are associated with lower risks of myopathy (versus gemfibrozil) This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access 189,00 per year only 15,75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Lets call them variations
And for many people in Knoxville and the surrounding communities, the answer is simpler than they expect
doi: 10.5114/wo.2018.82642 25 LuCWardPSKapoorGSRohleDTurcanSAbdel-WahabOet al
A laboratory study of different bacterial strains found that Lactobacillus species exhibited greater oxalate-degrading ability compared with Bifidobacteria (Mogna 2014)
Autism Res 9 , 350375 (2016)
